An admirable attempt, but many irreconcilable differences make a meaningful comparison difficult.
To compare rates of tumor recurrence after different treatment approaches, investigators performed a prospective cohort study of consecutive cases of nonmelanoma skin cancer (NMSC) treated at two practices in northern California — an urban, university-based practice and a Veterans Administration (VA)-affiliated practice. Data from a median follow-up period of 7.4 years were available for 1174 patients and 1488 tumors. The tumors had been treated with excision (38.3%), Mohs surgery (37.4%), and destruction by electrodessication/curettage (24.3%).
The overall 5-year recurrence rate was 3.3%; by treatment, recurrence rates were 2.1% with Mohs, 3.5% with excision, and 4.9% with destruction. These rates did not reach statistically significant dif…
Reviewing Author
DisclosuresConsultant / Advisory boardAmway
Editorial boards JAMA Dermatology; Dermatologic Surgery; Journal of Cosmetic Dermatology; Lasers in Medical Science; Skin Therapy Letter
Leadership positions in professional societies American Academy of Dermatology (Chair, Health Care Finance Committee); American College of Mohs Surgery (Board of Directors); American Society for Dermatologic Surgery (Board of Directors)
DisclosuresConsultant / Advisory boardAmway
Editorial boards JAMA Dermatology; Dermatologic Surgery; Journal of Cosmetic Dermatology; Lasers in Medical Science; Skin Therapy Letter
Leadership positions in professional societies American Academy of Dermatology (Chair, Health Care Finance Committee); American College of Mohs Surgery (Board of Directors); American Society for Dermatologic Surgery (Board of Directors)